24-09 Dr. Elie Dolgin 'Radiopharmaceuticals'

preview_player
Показать описание
Radioactive cancer-seeking drugs
00:00 Introduction
01:24 Insert - About the Prostate Forum
03:00 Dr. Elie Dolgin
47:50 Q&A

Tumor-seeking radiopharmaceuticals such as Pluvicto are charting a new course in the treatment of metastatic castration-resistant prostate cancer, promising to target malignant cells that express a protein called prostate specific membrane antigen (PSMA) with fewer side effects than conventional radiation therapy. In this clear, easily accessible, and well-illustrated presentation, science journalist Elie Dolgin, PhD, describes the history and current state of prostate cancer treatments in this area, including recent trials and developing drugs.

==== About the Prostate Forum ======

The Forum hosts monthly online support meetings (via Zoom) on the second and fourth Tuesday of most months, beginning at 5:00 pm Pacific Time.

At the Newly Diagnosed Group, every 2nd Tuesday at 5:00 pm Pacific Time, get help understanding your Prostate Cancer diagnosis. Learn what it means. Talk about your options.

At the Advanced/Recurrent Group Group every 4th Tuesday, beginning at 5:00 pm Pacific Time, share your concerns and experiences, and find out what other Prostate Cancer warriors are saying and thinking. Learn about resources, advances, and breakthroughs - advanced treatment options are improving all the time.

Monthly Presentations
Experts in the treatment and management of Prostate Cancer share their knowledge and experience with us on the fourth Thursday of most months.

All meetings are free and are open to anyone affected by prostate cancer – patients, family, friends.

• Register to receive notices of meetings
• Advocate for yourself: learn the language of prostate cancer.
• Find resources for learning and treatment
• Explore a library of a hundreds of expert presentations